Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AE6Y
|
|||
| Drug Name |
PMID26924192-Compound-106
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
UNIVERSITY OF DUNDEE CAMBRIDGE ENTERPRISE LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H21ClN4O3
|
|||
| Canonical SMILES |
CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2C(C)C(=O)OC)C4=CC=C(C=C4)Cl
|
|||
| InChI |
1S/C22H21ClN4O3/c1-12(22(28)30-4)19-21-26-25-13(2)27(21)18-10-9-16(29-3)11-17(18)20(24-19)14-5-7-15(23)8-6-14/h5-12,19H,1-4H3/t12-,19+/m1/s1
|
|||
| InChIKey |
FENXDXHDXYVGRJ-BLVKFPJESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain-containing protein 2 (BRD2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain-containing protein 2 (BRD2) | Target's Patent Info | [1] | |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathway Interaction Database | Regulation of retinoblastoma protein | |||
| WikiPathways | Chemical Compounds to monitor Proteins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.